Regional Deputy Director of US Partnerships

Regional Deputy Director of US Partnerships - Civil Service Jobs - GOV.UK You need JavaScript enabled to use this service. Cookies on Civil Service Jobs We'd like to use analytics cookies so we can understand how you use Civil Service Jobs and make improvements. We also use essential cookies to remember if you’ve accepted analytics cookies. Your cookie preferences have been set You have chosen to accept analytics cookies. You will be asked for your preferences again in 90 days. You can change your cookie settings at any time. Your cookie preferences have been set You have chosen to reject analytics cookies. You will be asked for your preferences again in 90 days. You can change your cookie settings at any time. Skip to main content GOV.UK Civil Service Jobs Beta Your feedback will help us to improve. Home Sign in to your account Cymraeg Regional Deputy Director of US Partnerships Medicines and Healthcare Products Regulatory Agency Apply before 11:55 pm on Sunday 1st November 2026 Return to search results Details Reference number 485291 Salary £86,000 - £117,800 A Civil Service Pension with an employer contribution of 28.97% GBP Job grade SCS Pay Band 1 Contract type Overseas Business area Innovation and Compliance Group Type of role Policy Senior leadership Working pattern Full-time Number of jobs available 1 Contents Location About the job Benefits Things you need to know Apply and further information Location Washington About the job Job summary The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK's sovereign regulator for medicines, including biological medicines, medical devices and blood products. At the heart of its purpose is protecting public health, ensuring that medical products available to patients are safe and effective while enabling innovation to reach patients appropriately. Today, that mission is increasingly international. Science and life sciences innovation do not stop at national borders, and neither can effective regulation. New medicines, technologies and ways of developing them are moving rapidly, making strong relationships between regulators, governments, researchers and industry more important than ever. For the MHRA, international partnerships are therefore not simply about exchanging information. They are about building the relationships and connections that allow regulators to respond intelligently to innovation, learn from one another and create opportunities to work together wh